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Widely consumed in foods and as an energy supplement, caffeine has been 
studied given its pharmacological effects, especially on Central Nervous System 
(CNS). In this sense, the present study investigated whether and to what extent 
caffeine chronic use can influence the brain oxidative status and the behavioral 
activity of the C57BL/6 female mice. For this, fifteen animals were randomized into 
the following groups: Control (0.9% saline solution), Caf10 (10 mg/kg caffeine), and 
Caf50 (50 mg/kg caffeine). The animals received one daily caffeine dose by i.p route 
for 120 days. Twenty-four hours after the last administration, the animals were 
subjected to behavioral tests and euthanized. The blood was used by biochemical 
analysis and the brain to evaluate the oxidative status and micromineral levels. The 
caffeine did not influence the anthropometric parameters, lipid profile, and C-
reactive protein levels. Further, superoxide dismutase (SOD) and glutathione-s-
transferase (GST) activities maintained the same response profile. On the other 
hand, catalase (CAT) activity was decreased in both groups receiving caffeine 
compared to the control group. Despite this, malondialdehyde and carbonyl 
protein levels did not change among the groups, as well as the distribution 
micromineral levels.  In the same way, no caffeine dose altered the findings of 
anxiety-like behaviors in the animals. Considering the time of caffeine 
administration, we believe that there was a cellular adaptation triggered by its use, 
tending to a protective effect on the brain. 
 




Amplamente consumida nos alimentos e como suplemento alimentar, a cafeína 
tem sido estudada devido aos seus efeitos farmacológicos, principalmente no 
sistema nervoso central (SNC). O presente estudo investigou se o uso crônico da 
cafeína pode influenciar o estado oxidativo do cérebro e a atividade 
comportamental de camundongos fêmeas C57BL/6. Para isso, quinze animais 
foram randomizados nos seguintes grupos: Controle (solução salina à 0,9%), Caf10 
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(10 mg / kg de cafeína) e Caf50 (50 mg / kg de cafeína). Os animais receberam 
uma dose diária de cafeína por via i.p. durante 120 dias. Vinte e quatro horas após 
a última administração, os animais foram submetidos a testes comportamentais 
e foram eutanasiados. O sangue foi utilizado para análises bioquímicas. No 
cérebro, foi avaliado o estado oxidativo e os níveis de microminerais. A cafeína não 
influenciou os parâmetros antropométricos, perfil lipídico e níveis de proteína C-
reativa. Ademais, as atividades de superóxido dismutase (SOD) e glutationa-S-
transferase (GST) mantiveram o mesmo perfil de resposta. Em contrapartida, a 
atividade da catalase (CAT) diminuiu em ambos os grupos que receberam 
cafeína.  Já os níveis de malondialdeído e proteína carbonilada não se alteraram 
entre os grupos, assim como a distribuição dos microminerais. Nenhuma dose de 
cafeína desencadeou comportamento do tipo ansioso nos animais. Portanto, 
considerando o tempo de administração da cafeína, acreditamos que houve a 
adaptação celular desencadeada pelo seu uso, tendendo a um efeito protetor no 
cérebro. Além disso, o espaço amostral reduzido foi uma limitação para 
entendimentos mais acurados sobre os efeitos da cafeína no SNC. 
 






Caffeine (1,3,7-trimethylxanthine) is present in the composition of a wide range of 
foods (e.g., coffee, tea, soft drinks, chocolate), energy drinks, and, commonly, it is 
used as an ergogenic feature for athletes (1). The effects of caffeine in the brain have 
been historically described as a psychostimulant, elucidated in behavioral 
investigations in both humans and rodents1–4. This molecule is a type of 
methylxanthine alkaloid and makes up the purine group, standing out for its 
antioxidant and stimulating potential of the central nervous system (CNS)5,6. Studies 
of the pharmacology of caffeine have pointed out that after its consumption and 
absorption by the organism, this natural molecule is quickly transported to the brain 
(half-life to 2-12 hours), being capable to influence the response of neurons (e.g., 
calcium release, ryanodine receptors agonist, trigger mitochondrial reactions), 
besides influencing the ionotropic receptor's activity (e.g., inhibition of 5’-
nucleotidases and dephosphorylate the GABAA receptor)7–11. 
Structurally, caffeine is similar to adenosine, an endogenous neuromodulator 
purine nucleoside released on the CNS, and that acts as a hormone over different 
receptors2,12. Studies have shown that the effects of this molecule on the CNS can 
reflect its action as a nonselective antagonist of these adenosine receptors (A1 and 
A2), with consequent blockade of A2A receptor densely located in the striatum 
nucleus, showing a positive relationship with the neuroprotector13,14. These 
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receptors A2A, when active, have been potentially associated with the control of the 
N-methyl-D-aspartate (NMDA) pathway that results in the production of caspase-
3 and reactive oxygen species (ROS) by mitochondrial pathway predisposing this 
way the tissues to suffer oxidative damage9,10. Additionally, the systemic effects of 
caffeine on A1 receptors could trigger lipolytic response profiles, which are usually 
related to modulation in serum lipid levels, such as cholesterol15–17. 
Due mainly to the influence of caffeine in the NMDA pathway, potential antioxidant 
effects of this compound have been reported in the nervous system10,18. This way, the 
imbalance between the reactive oxygen metabolites production and the 
downregulation of the endogenous antioxidant defense system has been closely 
associated with the oxidation and consequent functionality of lipids, proteins, and 
nucleic acids. Aligned with that fact, these mechanisms of oxidative stress besides 
predispose the loss of important cognitive and brain functions8,19, maintaining a 
close relationship with reactivity to stress and anxiety disorders20–23. In this 
perspective, Rammal et al.24 showed that anxious mice exhibited higher ROS 
accumulation in the neuronal and glial cells of three regions of the CNS (cortex, 
cerebellum, and hippocampus) when compared to the group of animals not linked 
to anxiety-related behaviors. Thus, the use of substances with antioxidant potential, 
as caffeine has been used as a pharmacotherapeutic co-adjuvant and 
neuroprotector, in the context of the neuronal and pathological changes in the CNS, 
including anxiety disorders and neurodegenerative conditions18,25,26. 
An efficient antioxidant mechanism is preponderant for minimizing the brain 
vulnerability of the brain against ROS attack. These facts have been commonly 
associated with the brain's high metabolic rates, its large concentration of 
polyunsaturated fatty acids (i.e., a target of free radical) with primordial regulatory 
functions, and lower levels of endogenous antioxidant enzymes of the brain tissue, 
compared to peripheral organs. Indeed, the brain cells undergo targets constant 
attacks by free radicals thus requiring the most effective defense mechanism27–29. In 
line with this fact, it is substantiated that the bioavailability of chemical elements as 
zinc (Zn), selenium (Se), and iron (Fe), besides participating as mediators in 
different cell signaling processes, when acting as enzymatic co-factors has the 
potential of the modulating the activity of antioxidant enzymes, thereby improving 
the system of defense brain against ROS attack10,28,29. Hereupon, it is notable that 
studies with rodents have shown that oxidative stress in the brain can reduce the 
bioavailability of these minerals30,31. 
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In this context, there have been frequent approaches involving the use of exogenous 
antioxidant substances, dietary and pharmacological ones, as coadjutants in the 
improvement of the oxidative function of the different tissues and organs32,33. Due to the 
high frequency of caffeine consumption, from stimulant for athletes to coffee intake by 
the world population, in addition to its notable antioxidant profile associated with 
neuroprotective properties, the present study was carried out to evaluate if and to what 
extent its chronic use, in two different doses, has the potential to influence the brain 
cells oxidative status and the behavioral activity in C57BL/6 mice. 
MATERIAL AND METHODS 
Animals, treatments, and biometrics 
Female C57BL/6 mice (8-week-old; n = 15) were kept in controlled environmental 
conditions (temperature 22 ± 2 °C, air humidity 60-70%, and 12/12 h daily 
light/darkness cycles). The animals were randomized into 3 groups with 5 animals 
per group as follows Control group (0,9% saline solution), Caf10 (10 mg/kg caffeine, 
and Caf50: 50 mg/kg caffeine. Food and water were provided ad libitum. The caffeine 
(Sigma, St Louis, MO, USA) was dissolved in 0.9% NaCl (sodium chloride) and 
provided daily by intraperitoneal (i.p.) dose for 120 days, a chronic exposition in 
rodents10,34. The experimental period and the caffeine doses were selected based on 
Hughes and Hancock35. Additionally, the doses administered were daily determined 
by animal weight measures. Twenty-four hours after the last caffeine dose 
administration, the behavioral activity of the animals was tested and they were 
anesthetized with tribromoethanol (250 mg/kg, i.p.) and euthanized by cardiac 
puncture for exsanguination. The blood was collected for biochemical analysis, 
while the whole brain was rapidly removed (< 1minute) and submerged on cold (4ºC) 
phosphate buffer saline (PBS; 50mM, pH 7.0), followed by the cortex dissection and 
storage (-80ºC). These frozen samples were subsequently used for enzymatic 
analysis to assess the oxidative brain profile and for the detection of microminerals 
levels in this tissue. The use of animals in this experiment was approved by the 
Ethics Committee on the Use of Animals (CEUA) of the Federal University of 
Jequitinhonha and Mucuri Valleys (Protocol: 047/2016). 
Food efficiency was evaluated during the experiment by obtaining parameters such 
as dietary intake (g/g mass/day), energy intake (kcal/g mass/day), and body mass 
(g). Dietary intake and body mass were recorded weekly. Energy intake was 
estimated based on the dietary intake using the reference values provided by each 
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chemical component of the diet (i.e., 4.0 kcal/g carbohydrate, 4 kcal/g protein, and 
9 kcal/g fat). The Tail-Muzzle length of the mice was measured with an inelastic 
measuring tape (e = 0.1 cm). The Lee index (Lee) = !!√#$
%&'
" and Body Mass Index (BMI) 
= #$
%&'!
 , were determined for obesity development assessment, where BW refers to the 
final body weight, and the naso-anal length36. 
Biochemical analysis 
The biochemical analysis was accomplished by quantifying plasma levels of total 
HDL cholesterol, LDL cholesterol, and C-reactive protein. These biochemical 
parameters were analyzed on a spectrophotometer.  Ultimately, the C-reactive 
protein was determined by using immunoturbidimetric assay, with the 
manufacturer's instructions (Bioclin, Belo Horizonte, Minas Gerais, Brazil). 
Enzymatic antioxidant activity 
The activity of antioxidant enzymes was investigated by using brain samples 
homogenized in ice-cold phosphate buffer (pH = 7.0) and centrifuged at 6200 rpm 
(5 °C, 15 min). The supernatant was used for the analysis of catalase (CAT), 
glutathione S-transferase (GST), and superoxide dismutase (SOD)37,38. CAT activity 
was evaluated according to the method described by Aebi39 by measuring the kinetics 
of hydrogen peroxide (H2O2) decomposition. SOD activity was estimated by the 
pyrogallol method based on the ability of this enzyme to catalyze the reaction of 
superoxide (O−2) and hydrogen peroxide (H2O2). GST activity was estimated by a 
spectrophotometer at 340 nm as described by Habig and Pabst40 and calculated from 
the rate of nicotinamide adenine dinucleotide phosphate oxidation. Total protein 
levels in the supernatant were measured using the Bradford method41. 
Lipid and protein oxidation 
Lipid peroxidation was evaluated from the quantification of thiobarbituric acid 
reactive substances (TBARS) according to a standardized biochemical colorimetric 
method. Briefly, the samples of the brain were homogenized in sodium phosphate 
buffer and centrifuged at 12.000 rpm for 10 min. The homogenate was collected and 
incubated with a thiobarbituric acid solution (0.375% thiobarbituric acid, 0.25N HCl, 
and 15% trichloroacetic acid) for 15min. TBARS levels were quantified 
spectrophotometrically at 535 nm38,42. Protein oxidation was estimated as the 
cerebral content of protein carbonyl (PCN)43. After homogenate removal, PCN 
content was measured in tissue pellets by the addition of 0.5 mL of 10 mM 
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dinitrophenylhydrazine (DNPH). The reaction is based on the derivatization of the 
carbonyl group with 2,4-DNPH, which leads to the complementary formation of a 
stable product (2,4-dinitrophenyl hydrazine). PCN content was measured 
spectrophotometrically at 370 nm42. 
Mineral microanalysis 
Brain content of sodium (Na), calcium (Ca), potassium (K), copper (Cu), magnesium 
(Mg), iron (Fe), zinc (Zn), and selenium (Se) were quantified by mass spectrometry44  
- ICP-MS (Elan DRC II, Perkin Elmer, USA) to induce the high-temperature plasma 
(1000K), discriminating the ions by the intensity of released energy. For this 
process, 0.35 g brain samples were dehydrated in a drying oven at 80 °C for 5 days 
until reaching constant mass. Samples were manually macerated and digested for 
24h in glass tubes containing 3 mL of sulfuric and nitric acid (1:1 v/v) at 30%. They 
were then heated in a microwave at 200 ºC for 20 minutes at 1000W. The samples 
were centrifuged at 2000 ×g, and 1 ml of the supernatant was dissolved in 20 ml of 
1.68 mol L-1 HNO3 solution. Mineral standards for Na, Ca, K, Cu, Mg, Fe, Zn, and Se 
were purchased from Sigma-Aldrich (TraceCERT – ICP-MS, Sigma-Aldrich Inc., St. 
Luis, Missouri, USA)38. 
Animal behavior tests 
Elevated plus-maze (EPM) test 
The EPM consisted of an apparatus made of wood composed of two closed arms 
(30x5x30 cm) and two open arms (30x5 cm) arranged such that the two open arms 
were opposite to each other, besides a central area (5x5 cm). Each open arm has on 
its side acrylic supports (1 cm), to avoid possible animal falls. The maze was elevated 
to a height of 40 cm on the floor. The image monitoring and record for subsequent 
analysis were performed using a Sony® camera, Handycam model, positioned set 
up above the EPM apparatus. The procedure was made according to described by 
Pellow et al. (1985). The animals were conducted in the behavior room of the 
Laboratório de Nutrição Experimental (LabNutrex) 30 minutes before the test for 
acclimatization. For test realization, each animal was placed in the central area of 
EPM with the head facing one of the closed arms, remaining isolated in the behavior 
room and its movements in the apparatus were filmed for 300 seconds. The variables 
evaluated were: the number and the ratio of entries in each arm (i.e., closed or open), 
characterized when the animal entered with four legs, the permanence time in each 
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of the arms, the ratio of entries, and the time spent in each arm according to 
following equations. 
Open field test 
The open field apparatus consisted of a white wood box measuring 30 cm wide by 30 
cm deep and 30 high. The box bottom was divided into 9 squares of 10 x 10 cm area 
each one, painted with black paint. This marking allowed the free movement of the 
animals by the total area of the box. The image monitoring and record for 
subsequent analysis were performed using a Sony® camera (Handycam model), 
positioned above the open field apparatus. The procedure was performed according 
to described by Teixeixa et al.46.  The animals were placed in the box center, and their 
behavior was filmed for 600 seconds. The variables evaluated were: the number of 
the square that the animals crossed completely (i.e., with the four legs); the lifting 
of body and maintaining of weight over the hind legs or Rearing; the number and 
permanence of the entrance in the square center and self-cleaning or Grooming.  
The hole-board test 
The hole-board apparatus consisted of a white wood plate (40 cm long by 40 cm 
wide and 5 cm deep). The plate has 16 holes equidistant with 3 cm in diameter and is 
coupled in a glass box with 40 cm long by 40 cm wide and 30 cm high. Monitoring 
and recording of images for later analysis were performed by the same digital 
structure of the last behavior test. The camera was positioned one meter in front of 
the perforated plate apparatus. The procedure was performed as described by Kuru 
et al.47. The animals were placed in the center of the plate and their behavior was 
filmed for 300 seconds. The variable evaluated was the number of diving (i.e., times 
the animal dipped its head in the holes of the plate). It was considered valid when 
the head lowered at least enough for the eyes to be immersed by the hole. 
Statistical analysis 
The normality distribution of data was verified by the Shapiro-Wilk test. Data with 
parametric distribution were analyzed using a one-way analysis of variance (one-
way ANOVA), followed by the Student-Newman-Keuls posthoc test. The non-
parametric distributed data were transformed by logarithmic transformation before 
the analysis to normalize the distribution. Proportion data were transformed by 
angular transformation before the analysis given their nature as percentages. Data 
were expressed as mean ± standard deviation (mean ± S.D.). All results with P ≤ 0.05 
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were considered statistically significant. Statistical analyzes were performed using 
GraphPad Prism 6.0 (GraphPad Software Inc., San Diego, CA, USA). 
RESULTS 
Caffeine, in both concentrations, contributed to maintaining the anthropometric 
parameters associated with the final body mass and energy intake (kcal/day). 
Moreover, this response profile did not influence the Lee index, the body mass index 
(BMI), and the tail-muzzle length in the experimental animals (p > 0.05). Similarly, 
the relation between the biomolecules of lipidic profile HDL and LDL and the 
inflammatory biomarker CPR (C reactive protein) maintained their baseline values 
compared to controls animals (p > 0.05; Table 1). In the same way, the relation 
between the biomolecules of lipidic profile HDL and LDL and the inflammatory 
biomarker CPR (C reactive protein) further maintained their baseline values 
compared to controls animals (p > 0.05; Table 1). Finally, caffeine did not influence 
the animals' weight gain compared to the control group (p > 0.05; Figure 1). 
Table 1 - Body mass, diet energy intake, biochemical analyzes, anthropometric measurements, and Lee index of 
experimental animals.  
HDL (High-Density Lipoprotein), LDL (Low-Density Lipoprotein), BMI (Body Mass Index). Control group, 
Caf10(10 mg/kg caffeine) and Caf50 (50 mg/kg caffeine). Different letters in the rows indicate the 
statistical difference between groups (P <0.05). 
Both doses of caffeine contributed to a significant decrease of catalase (CAT) levels 
in the brain tissue when compared to the control group (p < 0.05; Fig. 2B). On the 
other hand, the caffeine doses administered maintained the same baseline values of 
the cerebral superoxide dismutase (SOD) and glutathione-s-transferase (GST) of 
the control animals (p > 0.05; Figs 2A and C). Although we have observed a 
differential profile of response to the CAT enzyme, this was not sufficient to cause 
an imbalance between increased reactive oxygen metabolites and the enzymatic 
antioxidant defense system, once a time that no disorders associated with lipidic or 
protein oxidation (Fig. 3A and B) observed (p > 0.05). 
 
Control Caf10 Caf50 
Final body mass (g) 21.32 ± 0.62a 21.65 ± 1.0a 22.63 ± 0.83ª 
Energy intake (kcal/day) 71.29 ± 16.60a 75.67 ± 25.32a 67.59 ± 11.40a 
Lee Index (g/cm³) 167.50 ± 2.55a 166.60 ± 7.52a 170.70 ± 2.94a 
BMI (g/cm²) 1.28 ± 0.03a 1.29 ± 0.05a 1.36 ± 0.03a 
Tail-muzzle (cm) 16.56 ± 0.32a 16.76 ± 0.90a 16.58 ± 0.48a 
C-reactive protein (mg/L) 0.53 ± 0.09a 0.50 ± 0.05a 0.510 ± 0.03a 
HDL-cholesterol (mg/dL) 53.41 ± 4.44a 61.75 ± 14.0a 68.25 ± 4.14a 
LDL- cholesterol (mg/dL) 47.98 ± 9.68a 46.00 ± 10.26a 53.16 ± 4.76a 
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Figure 1 - Body mass over the 17 weeks (mean ± SE) from controls and caffeine doses. Control: animals 
received saline solution; Caf10 (caffeine 10 mg/kg); Caf50 (caffeine 50 mg/kg). Statistical differences between 
groups (P < 0.05) were not observed on this parameter.                                                                                                                                
 
 
Figure 2 - Superoxide dismutase (SOD), glutathione-s-transferase (GST), and catalase (CAT) activities in the brain 
from controls and caffeine doses. Control: animals received saline solution; Caf10 (caffeine 10 mg/kg); Caf50 
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Figure 3 - Malondialdehyde (MDA) and carbonyl protein (PCN) levels in the brain from controls and caffeine doses. 
Control group: animals received saline solution, Caf10(10 mg/kg caffeine) and Caf50 (50 mg/kg caffeine).  Different 
letters in the columns indicate the statistical difference between groups (P < 0.05). 
 
In association with this response profile, the bioavailability of brain chemical 
elements, such as sodium (Na), potassium (K), phosphor (P), calcium (Ca), copper 
(Cu), magnesium (Mg), iron (Fe), zinc (Zn) and selenium (Se), did not present 
modifications after caffeine intake in both caffeine doses (10 and 50 mg/kg) by 120 
days (p > 0.05; Table 2). 
Table 2 - Mineral content in the brain of mice treated with different caffeine doses. 
 
Control Caf10 Caf50 
Na (mg/g) 3.3 ± 0.2a 3.5 ± 0.3a 3.6 ±0.2a 
K (mg/g) 10.2 ± 1.5a 10.9 ± 1.7a 11.0 ± 1.2a 
P (mg/g) 11.9 ± 1.4a 10.6 ± 1.1a 12.0 ± 1.3a 
Ca (µg/g) 120 ± 7.1a 125 ± 8.8a 130 ± 10.6a 
Cu (µg/g) 199 ± 10.4a 182 ± 9.0a 202 ± 11.7a 
Mg (µg/g) 623 ± 11.7a 615 ± 13.9a 631 ± 15.2a 
Fe (µg/g) 277 ± 14.0a 269 ± 11.3a 280 ± 11.5a 
Zn (µg/g) 135 ± 7.5a 141 ± 6.3a 139 ± 7.0a 
Se (µg/g) 0.43 ± 0.05a 0.40 ± 0.08a 0.46 ± 0.05a 
Na(mg/kg), K (mg/g), P (mg/g), Ca (µg/g), Cu (µg/g), Mg (µg/g), Fe (µg/g), Zn (µg/g) and Se (µg/g) represent, 
respectively, sodium, potassium, calcium, copper, magnesium, iron, zinc and selenium concentrations. 
Control group, Caf10 (10 mg/kg caffeine) and Caf50 (50 mg/kg caffeine). Different letters in the rows 
indicate the statistical difference between groups (P < 0.05).  
In the elevated plus-maze (EPM) test, the same entry frequency in the arm open or 
arm closed was observed between the animals independent of the caffeine doses 
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period in both open arms and closed arms compared to the control group (p > 0.05; 
Fig 5C and 4D). 
Figure 4 - Quantitative analysis of the diving number of experimental animals in the Hole board test. Control group: 
animals received saline solution, Caf10(10 mg/kg caffeine) and Caf50 (50 mg/kg caffeine).  Different letters in the 
columns indicate the statistical difference between groups (P < 0.05). 
 
Figure 5 - Parameters in percentage obtained in elevated plus-maze (EPM) tests. Control group: animals received 
saline solution, Caf10(10 mg/kg caffeine) and Caf50 (50 mg/kg caffeine).  Different letters in the columns indicate the 
statistical difference between groups (P < 0.05). 
 
The quantitative parameters evaluated in the open-field test, such as body lifting, 
self-cleaning, squares crossed, entrances, and permanence in the square center 
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significant modifications to these parameters in the experimental animals 
compared to the control group (p > 0,05). The same response profile of the other 
behavioral tests was observed to the Hole board test, which was presented in Figure 
4 (A and B). The quantitative analysis of the diving number that experimental 
animals realized on the baseline was similar to the result after 120 days of 
consuming caffeine (p > 0.05). 
Figure. 6 - The open field tests; Control group: animals received a saline solution, Caf10(10 mg/kg caffeine) and Caf50 
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The historical findings of antioxidant and neuroprotective activities of caffeine 
supported in literature its use in experimental conditions in the present 
investigation4,35. In this context, we evaluate the relation of caffeine chronic use (2 
different doses daily by 120 days) over anthropometric parameters, serum 
biochemical analyzes, oxidative status, chemical elements bioavailability in the 
brain, besides behavioral tests in mice. The caffeine doses used in this murine study 
were designed considering the daily human consumption of this molecule. The 
lower dose (i.e., 10 mg/kg) was based on the global minimal caffeine consumption of 
about 2 to 7 cups (4 to 15 mg/kg/day respectively) and human supplementation (3-
9 mg/kg), as an ergogenic feature. In contrast, the highest dose (50 mg/kg) 
determination was outlined from behavior findings in experimental models in the 
literature10,18,34,35,48. Ultimately, due to the experimental need to mitigate stressors 
for rodents during the course of the study, especially by previous studies on behavior 
or chronic use of caffeine18,32,34,49,50, the decision to use the intraperitoneal route for 
the experimental protocol was determined.  
The consumption of thermogenic aliments has been closely associated as an 
important ally in accelerating weight loss51,52. In humans, LeBlanc et al.53 showed 
that the daily ingestion of a cup of coffee (4 mg/kg), is capable to increase the resting 
metabolic rate (RMR), suggesting the thermogenic effect of this substance. In 
experimental animals, Abreu et al.10 when administering caffeine in 20 and 40 mg/kg 
doses by a period of 80 days for male rats didn't report any bodyweight changes 
nether in the energy intake by these animals. In this same perspective, Xu et al.17 in 
their study with female rats ingesting 38,4 mg/kg of the caffeine by 13 weeks did not 
detect any interference associated with these same variables. Corroborating with 
these findings, in our investigation we also didn’t find any changes associated with 
final body mass or energy intake (kcal/day) in the animals receiving caffeine at both 
doses. Equally the parameters of tail-muzzle and, especially, Lee Index and body 
mass index (BMI), both variables with sustained dependence of the weight 
variation36, also maintained similar values compared to control animals, 
independently of the caffeine dose consumed. 
Studies have shown that the direct consequence of the caffeine binding to the 
adenosine receptor (A1) has close relation with the increase of the Cyclic Adenosine 
Monophosphate (cAMP)15, an important sign of the lipolysis activation pathway16. 
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This caffeine lipolytic profile associated with increased levels of the lipid circulating 
in the blood (e.g., total cholesterol, low-density lipoprotein (LDL), and 
triglycerides) had already been reinforced in different experimental studies54,55. A 
recent study confirmed that the modulation of the expression of promoter regions 
of cholesterol synthesis genes was increased at different concentrations of caffeine 
(i.e., 30, 60, and 120 mg/kg). The epigenetic investigation was conducted from the 
intragastric administration of caffeine in pregnant female rats and observation of 
the offspring. The genetic influence of the molecule was associated with an increase 
in serum total cholesterol and LDL17. Although these studies indicate the 
interference of caffeine over lipid metabolism, in our experimental protocol, the 120 
days of ingestion of this substance was not sufficient to support this affirmation. 
Contrary, its use contributed to keeping both the LDL and HDL cholesterol levels 
unchanged, independent of the dose consumed, maintaining them similar to the 
response profile presented by animals of the control group. We believe that caffeine 
chronic administration may have favored an adaptation mechanism associated with 
these variables 
In this same perspective, caffeine use contributed to the maintenance of a 
homeostatic microenvironment associated with cerebral oxidative status in the 
experimental animals. According to Vieira et al.5, the antioxidant activity of this 
substance is capable to reinforce the enzymatic response profile of SOD, GST, and 
CAT in overcoming the attack by free radicals (e.g., O2-, H2O2, OH-), maintaining 
the structural and functional integrity of tissues. Despite characteristically the 
caffeine keeps a positive relation influencing the tissue levels of antioxidant 
defense32, in our investigation, this substance presented a differential response 
profile. Independent of consumed caffeine dose, the SOD and GST enzyme levels 
maintained similar values to those found in the control group. Nevertheless, 
metabolic modulation in the counterbalancing effect system to oxidative damage 
was also found among an enzyme evaluated in our study. The SOD activity is related 
to the conversion of superoxide radicals into hydrogen peroxide (H2O2)56. 
Hereupon, this enzyme is only effective when the peroxide is used as a substrate for 
the action of CAT, which converts it into water molecules, consolidating the 
antioxidant effect57. Besides, peroxide can interact with the superoxide anion and 
trigger the production of the highly reactive hydroxyl radical. In this sense, it would 
be possible that the reduction of catalase activity contributed to increasing the 
vulnerability of rodents' brains to oxidative stress. However, despite the enzyme 
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variation of CAT, it did not compromise the endogenous antioxidant defense system 
in the brain, respectively by tissue levels of the malondialdehyde and carbonyl 
protein. Finally, due to the counterbalance and attack system (i.e., MDA and PCN), 
these results suggest that caffeine did not predispose to oxidative stress. 
This response profile of the antioxidant enzymes can be a relation to the 
maintenance of chemical element levels of microelements in brain tissue. According 
to Barbosa et al.58 microelements like Zn, Cu, Fe, and Se, besides assisting in 
processes associated with the integrity of brain metabolism (i.e., effective mediators 
of innate immune activation59, modulating the production of TNF-α, TIMP-1, and 
the blood capillary proliferation marker α-SMA)60, many of these minerals also 
function as enzymatic co-factors. In this sense, Zn and Cu for example, are required 
by superoxide dismutase for dismutation of superoxide anion to oxygen and 
hydrogen peroxide, while Fe is essential for enzymatic CAT activity61,62. Also, Se is a 
cofactor for glutathione peroxidase involved in the reduction of hydroperoxides in 
the cell63,64. Despite the functionality of these antioxidant enzymatic groups and the 
relevance of the minerals' co-factors balance, the caffeine in the experimental 
conditions evaluated in our investigation was not capable of influence these 
variables, corroborating with the maintenance of the activities of these respective 
antioxidant defense enzymes evaluated. 
It has been established that the balance between the endogenous antioxidant system 
and the attack by reactive oxygen and nitrogen metabolites are fundamentals for 
brain cells' integrity and, consequently, maintenance of the behavioral activities as 
the mobility and anxiety profile10,35. In this perspective, the review of Bishop et al.65 
showed a positive relationship between continuous oxidative damage in brain tissue 
(i.e., related to different ROS production pathways) and behavior activities 
functional decline. The modulation of the A2A receptor by caffeine has the potential 
to mitigate altered behavioral phenotypes in rats, as hyperlocomotion66 and 
potentiation of anxiety-like behavior67. Despite this premise, Hughes et al.35 when 
evaluating the behavior of animals who ingested 50 mg/kg/day caffeine by 20 days 
showed a hypomobility profile in the open field test compared to control, suggesting 
a differential response profile of this substance in cerebral activity. On the other 
hand, Abreu et al.10 did not see any caffeine effect (20-40 mg/kg/day) added to the 
diet on locomotor and exploratory activities. Similar to this similar caffeine 
response profile, in our investigation we also none saw any change among variables 
analyzed to the open field test after chronic intake of this substance by animals.  
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Equally, though the caffeine use had been closely associated to decrease anxiety-like 
behaviors in rats4,35, this substance was not capable of an induced change of these 
variables in the experimental animals in our study, evaluated by hole-board test. In 
this test, independent of caffeine dose, the frequency of diving in the apparatus was 
similar in all animals compared to the control group that received only water. In a 
study conducted by Pierard et al.48, the application of an experimental protocol that 
administered 16 mg/kg of caffeine (i.p. route), evidenced an induction to explore the 
hole-board, indicating an improvement in anxiety-like behaviors parameters. On 
the other hand, Çakir et al.4 evaluating the possibility of the protective effect of 
caffeine on anxiety in models of additional stress to rodents demonstrated that 
chronic (14 days) administration (3 mg/kg) of this molecule improved the level of 
anxiety before the exposure of additional stress.  
The caffeine, in dose and time of administration in our investigation, was also not 
capable of influencing any parameters of the elevated plus-maze test, suggesting a 
disparate demeanor of its protective effect. Corroborating with this finding, 
Arendash et al.68 did not see one cognitive change associated with anxiety levels in 
animals after a chronic (i.e., 6 weeks) daily intake of 1.5 mg of caffeine. On the other 
hand, Hughes et al.35 evidenced a reduction of the time spent by animals in the open 
arm of the apparatus after intake 50 mg/kg/day of caffeine by 20 days suggesting an 
increase in anxiety signals.  
Considering the exposure, although the literature is consistent in pointed the 
effectiveness of the intake of thermogenic drinks with considerable antioxidant 
effect as the caffeine, besides its psychostimulating potential, these studies, for the 
most part, are quite heterogeneous, especially related to the dose consumed and to 
time of caffeine administration. This fact has been reflected in differential response 
profiles consistent with positive, negative, and/or adaptive effects associated with 
using this substance. Lined up with these observations, in our investigation the 
caffeine at 10 and 50 mg/kg dose administered daily for 120 days showed no evidence 
of significant improvement on brain oxidative status. Despite this fact, we did not 
observe any significant oxidative damage. This response profile was also consistent 
with the behavioral analysis of the animals that maintained their baseline values, 
similar to the control animals. Considering the time of caffeine administration to the 
animals, we believe that there was a process of cellular adaptation triggered by its 
chronic use. However, to confirm or refute this inference believed to be a necessary 
realization of more detailed studies evaluating the consumption of caffeine variable 
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doses alternating of the time (e.g., acute, subacute, and chronic). Another important 
fact that can be associated with the limitation of this study refers to the sample 
number, despite the statistical adequacy of the analyzes performed. Despite this 
fact, in general, our findings reinforced the potential effects of caffeine over the 
oxidative status and brain functionality in mice. 
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